BCM
SRRA

BCK Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

BCK Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,500
Closed -$1.02M – 120
2022
Q2 		$1.02M Buy
+18,500
New +$971K 0.79% 37

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

BCK Capital Management's SRRA Position: Q3 2022 in Review

BCK Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 18,500 shares — an estimated $1.02M sold.

BCK Capital Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $1.02M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • BCK Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • BCK Capital Management sold 18,500 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.02M.
  • BCK Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • BCK Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $1.02M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on BCK Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.